MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An Interview With Alec Vahanian, MD
Dr. Vahanian shares his thoughts on the updated ESC/EACTS guidelines and the ongoing evolution of valvular intervention.
Sponsored by Valtech
The Cardioband System for Treatment of Secondary MR
Technology that presents a promising alternative to traditional surgery.
By Alec Vahanian, MD, and David Messika-Zeitoun, MD, PhD
Long-Term Efficacy of Percutaneous Mitral Commissurotomy for Mitral Stenosis
After successful PMC, what do the results show at 20 years?
By Alec Vahanian, MD, and Bernard Iung, MD
Coronary Sinus and Direct Annuloplasty Approaches for Percutaneous Mitral Valve Repair
With device design improvements, proper patient selection, and careful technique, percutaneous coronary sinus annuloplasty may be a viable treatment option for mitral regurgitation.
By Alec Vahanian, MD
Outcomes Reported for Edwards' Sapien 3 TAVR System in Intermediate-Risk Patients
May 20, 2015—Edwards Lifesciences Corporation announced that 30-day outcomes for intermediate-risk patients treated transfemorally with the Sapien 3 transcatheter aortic valve replacement (TAVR) system demonstrated very low mortality and stroke rates with no severe paravalvular leaks.
2021 European Valvular Heart Disease Guidelines Are Published by ESC/EACTS Task Force
August 28, 2021—The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) announced the publication of the 2021 ESC/EACTS guidelines for the management of valvular heart disease (VHD).
TAVI Included in 2012 European Joint Guidelines on Valvular Disease
August 25, 2012—At the European Society of Cardiology (ESC) Congress 2012 in Munich, Germany, the ESC announced the new clinical practice guidelines on the management of valvular heart disease from the Joint Task Force of the ESC and European Society of Cardio-Thoracic Surgery (EACTS).
Structural and Valvular Update
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
Expanding the Possibilities of PCI
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Worldwide Trends in TAVR
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
New-Onset Atrial Fibrillation After TAVI Studied
January 10, 2012—In the Journal of the American College of Cardiology, Ignacio J. Amat-Santos, MD, et al published findings from a study that sought to evaluate the incidence, predictive factors, and prognostic value of new-onset atrial fibrillation (AF) after transcatheter aortic valve implantation (TAVI) (2012;59:178–188).
